Nonprofit initiates new fund to assist Medicare patients with kidney cancer

HealthWell fund will provide financial assistance to under-insured patients with renal cell carcinoma.01/01/2016
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news

Related Links:

In this study, we utilized human carbonic anhydrase 9 (hCA9) as a model neoantigen of mouse RENCA RCC. hCA9-expressing RENCA RCC (RENCA/hCA9) cells were rejected in young mice but grew in aged mice. CD8+ T cells were the primary effector cells involved in rejection in young mice, whereas CD4+ T cells participated at the early stage. Screening of a panel of hCA9-derived peptides revealed that mouse CD8+ T cells responded to hCA9288 –296 peptide. Mouse CD4+ T cells responded to lysates of RENCA/hCA9, but not RENCA cells, and showed reactivity to hCA9276 –290, which shares three amino acids with hCA9288 –296...
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
In this study, we employed an integrative analysis framework of functional genomics approaches and machine learning methods to the lncRNA, miRNA, and mRNA data and identified 16 RNAs (3 lncRNAs, 6 miRNAs, and 7 mRNAs) of prognostic value with 9 of them novel. We then established a 16-RNA-based score for prognosis prediction of ccRCC with significance (p-value
Source: The American Journal of Pathology - Category: Pathology Authors: Source Type: research
In conclusion, the results from the present study indicated that PARK2 may signal via CKS2 to affect tumor behavior. In consequence, CKS2 may be a biomarker in ccRCC and may also serve as potential target for ccRCC therapy.PMID:35059737 | DOI:10.3892/ijo.2022.5310
Source: International Journal of Oncology - Category: Cancer & Oncology Authors: Source Type: research
CONCLUSIONS: Such results suggest that PFKFB3 is a key molecular player in RCC progression via mediating glycolysis / proliferation and provides a potential therapeutic target against RCC.PMID:35057732 | DOI:10.1186/s12885-022-09183-2
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research
Conclusion: In summary, our results provided evidence for studying the potential function of RNA m6A modification and m6A-mediated gene expression regulation in human RCC.
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research
Nature Reviews Urology, Published online: 21 January 2022; doi:10.1038/s41585-022-00568-3Prognostic models are crucial for optimal management of patients with renal cell carcinoma (RCC) after surgery. Multiple clinico-pathological models to predict cancer outcomes in these patients exist and seem to have reached their performance ceiling. Future research needs to identify new prognostic markers and to consider when and how prognostic models for RCC are implemented into practice.
Source: Nature Reviews Urology - Category: Urology & Nephrology Authors: Source Type: research
h Hsu Ken Batai American Indians/Alaska Natives (AI/AN) and Hispanic Americans (HA) have higher kidney cancer incidence and mortality rates compared to non-Hispanic Whites (NHW). Herein, we describe the disparity in renal cell carcinoma (RCC) surgical treatment for AI/AN and HA and the potential association with mortality in Arizona. A total of 5111 stage I RCC cases diagnosed between 2007 and 2016 from the Arizona Cancer Registry were included. Statistical analyses were performed to test the association of race/ethnicity with surgical treatment pattern and overall mortality, adjusting for patients’ demogra...
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
This study aims at describing the imaging features of the metastatic presentation of clear cell renal cell carcinoma (ccRCC) in arterial (AP) and portal venous phase (PVP) of contrast-enhanced-computed-tomogra...
Source: Cancer Imaging - Category: Radiology Authors: Tags: Research article Source Type: research
We present the case of a patient with an aggressive course of this neoplasm treated with temsirolimus, who achieved 10-month control of this neoplasm accompanied by a discussion on other therapeutic possibilities.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Cancer cells prefer utilizing aerobic glycolysis in order to exacerbate tumor mass and maintain un-regulated proliferative rates. As a key glycolytic activator, phosphofructo-2-kinase/fructose-2,6-bisphosphata...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Insurance | Kidney Cancer | Medicare | Renal Cell Carcinoma | Uninsured | Urology & Nephrology